Recently, enhanced hepatic gluconeogenesis and glucose output were observed in the Cav-1 null mice [70], and suppressed glycolysis was noted in Cav-1 reconstituted breast cancer epithelial cells [71], suggesting its implication in glucose metabolism. Here, CAV1 is linked to breast carcinoma.